Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adjusted xiaoyaosan decoction (also known as Jiawei Xiaoyaosan or Danzhi Xiaoyaosan) is a traditional Chinese medicine (TCM) herbal formula widely used for the treatment of psychological stress-related disorders, including insomnia, anxiety, and depression. It is a modified version of the classic Xiaoyaosan formula, typically prepared by adding Moutan Cortex (Danpi) and Gardeniae Fructus (Zhizi) to clear heat and soothe the liver. The decoction is thought to exert its therapeutic effects by regulating the hypothalamic-pituitary-adrenal (HPA) axis, modulating central neurotransmitters such as dopamine, serotonin, and norepinephrine, and reducing neuroinflammation. It has been evaluated in clinical trials, including a Phase IV study by The Second Hospital Affiliated to Guangzhou University of TCM, both as a monotherapy and in combination with sedative-hypnotics like estazolam (surazepam) for patients with psychological stress-related psychophysiological insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on adjusted xiaoyaosan decoction.